‘Staggeringly high’ discontinuation rates for GLP-1 drugs like Ozempic or Wegovy

The use of diabetes and weight-loss medications like Ozempic or Wegovy—called GLP-1 drugs—has exploded in recent years, with 12% of U.S. adults having used one despite the high cost, according to a June 2024 poll.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup